Global Cold Agglutinin Disease Market Research Report 2022
SKU ID : QYR-21177675 | Publishing Date : 29-Jun-2022 | No. of pages : 91
Detailed TOC of Global Cold Agglutinin Disease Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Agglutinin Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Corticosteroids
1.2.3 Alkylating Agents
1.2.4 Purine Nucleoside Analogs
1.2.5 Biologics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cold Agglutinin Disease Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cold Agglutinin Disease Market Perspective (2017-2028)
2.2 Cold Agglutinin Disease Growth Trends by Region
2.2.1 Cold Agglutinin Disease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cold Agglutinin Disease Historic Market Size by Region (2017-2022)
2.2.3 Cold Agglutinin Disease Forecasted Market Size by Region (2023-2028)
2.3 Cold Agglutinin Disease Market Dynamics
2.3.1 Cold Agglutinin Disease Industry Trends
2.3.2 Cold Agglutinin Disease Market Drivers
2.3.3 Cold Agglutinin Disease Market Challenges
2.3.4 Cold Agglutinin Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Agglutinin Disease Players by Revenue
3.1.1 Global Top Cold Agglutinin Disease Players by Revenue (2017-2022)
3.1.2 Global Cold Agglutinin Disease Revenue Market Share by Players (2017-2022)
3.2 Global Cold Agglutinin Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold Agglutinin Disease Revenue
3.4 Global Cold Agglutinin Disease Market Concentration Ratio
3.4.1 Global Cold Agglutinin Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Agglutinin Disease Revenue in 2021
3.5 Cold Agglutinin Disease Key Players Head office and Area Served
3.6 Key Players Cold Agglutinin Disease Product Solution and Service
3.7 Date of Enter into Cold Agglutinin Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Agglutinin Disease Breakdown Data by Type
4.1 Global Cold Agglutinin Disease Historic Market Size by Type (2017-2022)
4.2 Global Cold Agglutinin Disease Forecasted Market Size by Type (2023-2028)
5 Cold Agglutinin Disease Breakdown Data by Application
5.1 Global Cold Agglutinin Disease Historic Market Size by Application (2017-2022)
5.2 Global Cold Agglutinin Disease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cold Agglutinin Disease Market Size (2017-2028)
6.2 North America Cold Agglutinin Disease Market Size by Country (2017-2022)
6.3 North America Cold Agglutinin Disease Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cold Agglutinin Disease Market Size (2017-2028)
7.2 Europe Cold Agglutinin Disease Market Size by Country (2017-2022)
7.3 Europe Cold Agglutinin Disease Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Agglutinin Disease Market Size (2017-2028)
8.2 Asia-Pacific Cold Agglutinin Disease Market Size by Country (2017-2022)
8.3 Asia-Pacific Cold Agglutinin Disease Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cold Agglutinin Disease Market Size (2017-2028)
9.2 Latin America Cold Agglutinin Disease Market Size by Country (2017-2022)
9.3 Latin America Cold Agglutinin Disease Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Agglutinin Disease Market Size (2017-2028)
10.2 Middle East & Africa Cold Agglutinin Disease Market Size by Country (2017-2022)
10.3 Middle East & Africa Cold Agglutinin Disease Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Cold Agglutinin Disease Introduction
11.1.4 Sanofi Revenue in Cold Agglutinin Disease Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Cold Agglutinin Disease Introduction
11.2.4 Pfizer Inc. Revenue in Cold Agglutinin Disease Business (2017-2022)
11.2.5 Pfizer Inc. Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Detail
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Cold Agglutinin Disease Introduction
11.3.4 GlaxoSmithKline plc Revenue in Cold Agglutinin Disease Business (2017-2022)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Cold Agglutinin Disease Introduction
11.4.4 Novartis AG Revenue in Cold Agglutinin Disease Business (2017-2022)
11.4.5 Novartis AG Recent Development
11.5 Zydus Cadila
11.5.1 Zydus Cadila Company Detail
11.5.2 Zydus Cadila Business Overview
11.5.3 Zydus Cadila Cold Agglutinin Disease Introduction
11.5.4 Zydus Cadila Revenue in Cold Agglutinin Disease Business (2017-2022)
11.5.5 Zydus Cadila Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cold Agglutinin Disease Introduction
11.6.4 AstraZeneca Revenue in Cold Agglutinin Disease Business (2017-2022)
11.6.5 AstraZeneca Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cold Agglutinin Disease Introduction
11.7.4 Johnson & Johnson Revenue in Cold Agglutinin Disease Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Detail
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Cold Agglutinin Disease Introduction
11.8.4 Bayer AG Revenue in Cold Agglutinin Disease Business (2017-2022)
11.8.5 Bayer AG Recent Development
11.9 Sun Pharmaceutical Industries Ltd.
11.9.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.9.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Introduction
11.9.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Agglutinin Disease Business (2017-2022)
11.9.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.10 Apellis Pharmaceuticals
11.10.1 Apellis Pharmaceuticals Company Detail
11.10.2 Apellis Pharmaceuticals Business Overview
11.10.3 Apellis Pharmaceuticals Cold Agglutinin Disease Introduction
11.10.4 Apellis Pharmaceuticals Revenue in Cold Agglutinin Disease Business (2017-2022)
11.10.5 Apellis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Cold Agglutinin Disease Market Research Report 2022
List of TablesTable 1. Global Cold Agglutinin Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Alkylating Agents
Table 4. Key Players of Purine Nucleoside Analogs
Table 5. Key Players of Biologics
Table 6. Key Players of Others
Table 7. Global Cold Agglutinin Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Cold Agglutinin Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Cold Agglutinin Disease Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Cold Agglutinin Disease Market Share by Region (2017-2022)
Table 11. Global Cold Agglutinin Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Cold Agglutinin Disease Market Share by Region (2023-2028)
Table 13. Cold Agglutinin Disease Market Trends
Table 14. Cold Agglutinin Disease Market Drivers
Table 15. Cold Agglutinin Disease Market Challenges
Table 16. Cold Agglutinin Disease Market Restraints
Table 17. Global Cold Agglutinin Disease Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Cold Agglutinin Disease Market Share by Players (2017-2022)
Table 19. Global Top Cold Agglutinin Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Agglutinin Disease as of 2021)
Table 20. Ranking of Global Top Cold Agglutinin Disease Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Cold Agglutinin Disease Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cold Agglutinin Disease Product Solution and Service
Table 24. Date of Enter into Cold Agglutinin Disease Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cold Agglutinin Disease Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Cold Agglutinin Disease Revenue Market Share by Type (2017-2022)
Table 28. Global Cold Agglutinin Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Cold Agglutinin Disease Revenue Market Share by Type (2023-2028)
Table 30. Global Cold Agglutinin Disease Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Cold Agglutinin Disease Revenue Market Share by Application (2017-2022)
Table 32. Global Cold Agglutinin Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Cold Agglutinin Disease Revenue Market Share by Application (2023-2028)
Table 34. North America Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Cold Agglutinin Disease Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Cold Agglutinin Disease Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million)
Table 44. Sanofi Company Detail
Table 45. Sanofi Business Overview
Table 46. Sanofi Cold Agglutinin Disease Product
Table 47. Sanofi Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 48. Sanofi Recent Development
Table 49. Pfizer Inc. Company Detail
Table 50. Pfizer Inc. Business Overview
Table 51. Pfizer Inc. Cold Agglutinin Disease Product
Table 52. Pfizer Inc. Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 53. Pfizer Inc. Recent Development
Table 54. GlaxoSmithKline plc Company Detail
Table 55. GlaxoSmithKline plc Business Overview
Table 56. GlaxoSmithKline plc Cold Agglutinin Disease Product
Table 57. GlaxoSmithKline plc Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 58. GlaxoSmithKline plc Recent Development
Table 59. Novartis AG Company Detail
Table 60. Novartis AG Business Overview
Table 61. Novartis AG Cold Agglutinin Disease Product
Table 62. Novartis AG Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 63. Novartis AG Recent Development
Table 64. Zydus Cadila Company Detail
Table 65. Zydus Cadila Business Overview
Table 66. Zydus Cadila Cold Agglutinin Disease Product
Table 67. Zydus Cadila Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 68. Zydus Cadila Recent Development
Table 69. AstraZeneca Company Detail
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Cold Agglutinin Disease Product
Table 72. AstraZeneca Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Cold Agglutinin Disease Product
Table 77. Johnson & Johnson Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Bayer AG Company Detail
Table 80. Bayer AG Business Overview
Table 81. Bayer AG Cold Agglutinin Disease Product
Table 82. Bayer AG Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 83. Bayer AG Recent Development
Table 84. Sun Pharmaceutical Industries Ltd. Company Detail
Table 85. Sun Pharmaceutical Industries Ltd. Business Overview
Table 86. Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Product
Table 87. Sun Pharmaceutical Industries Ltd. Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 88. Sun Pharmaceutical Industries Ltd. Recent Development
Table 89. Apellis Pharmaceuticals Company Detail
Table 90. Apellis Pharmaceuticals Business Overview
Table 91. Apellis Pharmaceuticals Cold Agglutinin Disease Product
Table 92. Apellis Pharmaceuticals Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million)
Table 93. Apellis Pharmaceuticals Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cold Agglutinin Disease Market Share by Type: 2021 VS 2028
Figure 2. Corticosteroids Features
Figure 3. Alkylating Agents Features
Figure 4. Purine Nucleoside Analogs Features
Figure 5. Biologics Features
Figure 6. Others Features
Figure 7. Global Cold Agglutinin Disease Market Share by Application in 2021 & 2028
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Homecare Case Studies
Figure 11. Others Case Studies
Figure 12. Cold Agglutinin Disease Report Years Considered
Figure 13. Global Cold Agglutinin Disease Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Cold Agglutinin Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Cold Agglutinin Disease Market Share by Region: 2021 VS 2028
Figure 16. Global Cold Agglutinin Disease Market Share by Players in 2021
Figure 17. Global Top Cold Agglutinin Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Agglutinin Disease as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Cold Agglutinin Disease Revenue in 2021
Figure 19. North America Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Cold Agglutinin Disease Market Share by Country (2017-2028)
Figure 21. United States Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Cold Agglutinin Disease Market Share by Country (2017-2028)
Figure 25. Germany Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Cold Agglutinin Disease Market Share by Region (2017-2028)
Figure 33. China Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Cold Agglutinin Disease Market Share by Country (2017-2028)
Figure 41. Mexico Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Cold Agglutinin Disease Market Share by Country (2017-2028)
Figure 45. Turkey Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Sanofi Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 48. Pfizer Inc. Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 50. Novartis AG Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 51. Zydus Cadila Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 52. AstraZeneca Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 53. Johnson & Johnson Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 54. Bayer AG Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 55. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 56. Apellis Pharmaceuticals Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Keyplayers in Global Cold Agglutinin Disease Market Research Report 2022
SanofiPfizer Inc.
GlaxoSmithKline plc
Novartis AG
Zydus Cadila
AstraZeneca
Johnson & Johnson
Bayer AG
Sun Pharmaceutical Industries Ltd.
Apellis Pharmaceuticals